Track Mounjaro symptoms beside dose timing, injection sites, food, water, bowel changes, weight, and progress.
MeAgain is the best default Mounjaro side effect tracker app for people who want symptoms connected to the rest of the Mounjaro routine: dose timing, injection sites, food, protein, fiber, water, bowel changes, weight trend, progress photos, and medication-level context. It tracks the 18 most common GLP-1 side effects — nausea, constipation, diarrhea, vomiting, abdominal pain, dyspepsia, reflux, fatigue, headache, dizziness, injection-site reactions, and more — plus unlimited custom symptoms with a 0–10 severity slider, timestamps, and notes. Mounjaro is Eli Lilly's once-weekly tirzepatide shot prescribed by a licensed clinician for type 2 diabetes glycemic control (Zepbound contains the same active ingredient and is FDA-approved for chronic weight management instead). MeAgain does not manage diabetes, set glucose targets, prescribe Mounjaro, or provide glycemic-control guidance — it helps you track the routine your clinician prescribed. If symptoms seem to show up around dose day or after a step-up, tracking dose timing beside symptoms can make the pattern easier to see. 400,000+ people use MeAgain; 4.8 stars across over 18,000 App Store ratings; available on iPhone and Android.
Bottom line: MeAgain is for tracking and education. It does not diagnose symptoms, decide whether a symptom is dangerous, or recommend dose changes. Talk with a licensed clinician about severe, persistent, unusual, or concerning Mounjaro symptoms.
| Track | Why |
|---|---|
| Mounjaro dose and timing | Keeps symptoms near dose day |
| Day after shot | Helps show timing patterns |
| Recent dose change | Helps explain new or changing symptoms |
| Symptom and severity | Makes changes easier to compare |
| Food and water | Adds context to GI symptoms |
| Bowel changes | Useful for constipation/diarrhea context |
| Weight and appetite | Shows broader progress context |
| Notes for your clinician | Makes the next visit easier to prepare |
What MeAgain does not do: No medical advice, no diagnosis, no treatment, no insurance billing. MeAgain is a tracking and education app, not a clinical service — clinical decisions stay with your licensed clinician.
MeAgain is the Mounjaro side effect tracker app where every symptom log connects to dose day, injection sites, food, water, bowel changes, weight, and progress on one timeline.
Log nausea, constipation, diarrhea, vomiting, abdominal pain, fatigue, headache, and injection-site soreness — the 18 most common GLP-1 symptoms — plus unlimited custom symptoms with a 0–10 severity slider.
Mounjaro is a once-weekly tirzepatide shot for type 2 diabetes (Zepbound contains the same active ingredient for weight management). If symptoms seem to show up around dose day or after a step-up, tracking dose timing beside symptoms can make those patterns easier to see and discuss with a clinician.
After any Mounjaro dose change a clinician prescribes, the timeline lets you compare the new dose week to the previous one — useful for clinician check-ins where you want notes instead of memory.
400,000+ users track GLP-1 with MeAgain, and the app has a 4.8-star App Store rating across 18,000+ ratings and is available on iPhone and Android.

The labeled Mounjaro schedule starts at 2.5 mg once weekly and may increase in steps under clinician direction, with maintenance options on the FDA label. Your prescribed schedule may differ. MeAgain tracks the dose routine your clinician prescribed; it does not recommend dose changes. Some users notice that symptoms feel different right after a shot or step-up — and the dose history next to your symptom log makes those patterns easier to read. Every shot you log lands on the dose-day timeline with a timestamp, and the injection-site map records where the shot went, so site soreness has a location attached. When a clinician prescribes a dose increase, the change date stays on the timeline — which means you can compare the first week on a new dose against the last week on the old one, entry by entry.

MeAgain includes the 18 most common GLP-1 side effects — nausea, constipation, diarrhea, vomiting, abdominal pain, dyspepsia, reflux, fatigue, headache, dizziness, injection-site reactions, and more — plus unlimited custom symptoms when the preset list does not fit. The 0–10 severity slider, timestamps, and notes turn each entry into something useful later: not just a flag that something happened, but enough context to compare one rough day to another. If something shows up that the 18 presets do not cover — a taste change, a sleep shift, a specific food aversion — you can add it as a custom symptom, and it gets the same severity slider, timestamps, and notes as the built-in list. Severity scores earn their keep at clinician check-ins: a dated 7-of-10 nausea entry says more than a vague memory of a rough week.

Mounjaro side effects often overlap with food and hydration. A larger meal may sit longer. A low-water stretch may show up as fatigue or headache. Constipation often follows low-fiber days. MeAgain keeps food, protein, fiber, water, and bowel-change logs on the same timeline as the symptom log — so a rough week is something you can read instead of trying to reconstruct. Appetite changes are part of the same picture: when you are eating much less than usual, protein and water are easy to miss, and the logs show that drop right next to the days fatigue or headache entries appear. The weight trend sits on the same timeline too, so symptom stretches and weight changes stay in one view instead of living in separate apps.

MeAgain helps you remember what happened and bring clearer notes to a clinician conversation. It does not diagnose Mounjaro side effects, decide whether a symptom is dangerous, or recommend dose changes. Talk with a licensed clinician about severe, persistent, unusual, or concerning symptoms — including severe abdominal pain, persistent vomiting, signs of dehydration, trouble breathing or swallowing, or yellowing skin. What the app does do is make the check-in easier to prepare: severity scores with timestamps, the dose-day timeline with any dose increases marked, food and water context for the week, bowel-change notes, weight trend, and progress photos all live in one place. You arrive with a record instead of a recollection — and the clinician, not the app, decides what any of it means.
Mounjaro is Eli Lilly's tirzepatide injection FDA-approved for type 2 diabetes glycemic control, while Zepbound contains the same active ingredient and is FDA-approved for chronic weight management. The labeled Mounjaro schedule starts at 2.5 mg once weekly and may increase in steps under clinician direction, with maintenance options on the FDA label; your prescribed schedule may differ. In the SURPASS-1 and SURPASS-5 trials behind the FDA label's side-effect table, the most common side effects were nausea (12–18%) and diarrhea (12–17%), with GI symptoms typically peaking in weeks two through four and fading by weeks six to eight as tirzepatide levels stabilize. MeAgain does not manage diabetes or set glucose targets — it helps you track the routine your clinician prescribed alongside symptoms.
Some symptoms can have multiple possible causes, especially for people managing type 2 diabetes — dizziness, sweating, shakiness, confusion, and similar feelings can have many origins. If you have any blood-sugar concerns, follow your clinician's guidance and use the tools they recommend for glucose monitoring. MeAgain logs Mounjaro symptoms with timestamps so you can keep the symptom timeline clear, but it does not replace diabetes care, glucose-management guidance, or glycemic-target advice.
This page focuses on the tracking workflow — what to log when Mounjaro side effects show up and how MeAgain keeps that connected to dose timing, food, water, weight, and progress.
For medical background — what Mounjaro side effects are, how often they happen in clinical trials, what to talk through with a clinician — see our Mounjaro side effects guide. For the broader weekly Mounjaro tracker (dose, food, weight, progress), see the Mounjaro App page.
Sources
One App Store reviewer, Eric Seals, wrote:
I really love this app and how easy it is to use for my food, water, Mounjaro weekly shot and everything else.
That is the job this tracker does for Mounjaro: the weekly shot, food, and water live on one timeline with the symptom log, so a rough week becomes a pattern you can read — and bring to a clinician as notes instead of memory.

“I've been using the app for about 7 months now and I love how I'm able to track my meals and my daily medication. The little capybara widget is a great visual to help me know what my body needs.”
“The Me Again app has been super helpful for managing my Wegovy journey. I love the reminder features and how easy it is to change the units — those tools make staying on track so much easier.”
“I really love this app and how easy it is to use for my food, water, Mounjaro weekly shot and everything else. The app is totally worth the cost and it's been perfect for me.”
“I've been on my MJ journey since September 2025. Seeing my food intake has made a huge difference. Also, reviewing my shot locations has helped me remember to rotate. I have recommended this app to my friends who have also started their own journeys!”
“I honestly really like this app! It has been very useful in helping me track my protein and water while on tirzepatide. I love the cutie capybara I have to take care of every day, it's motivating!”
Track the symptom, severity on a 0–10 scale, dose timing (which day after the shot), food before the symptom, water and fiber, bowel changes, weight, and any notes about how the day felt. MeAgain keeps each of those fields on one timeline so a rough week is something you can read instead of guess.

Track the plan, dose, meals, and milestones in one place that actually keeps up with your day.